About
PROSTPERIA aims at researching and developing new "in silico" screening tests for several cancers. At PROSTPERIA we want to make personalized medicine a reality by steering clear of the "one size fits all" model. Our first test, PROSTia, targets the early detection of prostate cancer.
Technologies
Mobile FriendlyGoogle Tag ManagerTypekitAIIoTAndroidNode.js
Keywords
medical equipment manufacturinghealthtechmedical ai validationcancer detectioncomplex phenomena modelingmedical devicecost-effective screeningpersonalized medicinepersonalized screeningrisk assessmenthealthcaremedical devicesretrospective studypsa testdiagnostic toolscancer prediction modelsbiotechmedical researchmachine learningmedical aipersonalized diagnosticsbiomarker analysistelemedicineb2cbiological servicesnon-invasive testpatient careclinical validationearly detectionpatient data analysis
Company Information
- Employees4
- Founded2021
Location
10 Rue Victor Poirel, Nancy, Grand Est, France, 54000
